Articles from Merz Aesthetics

Merz Aesthetics® Canada announced today the Health Canada approval for Radiesse® for the treatment of moderate wrinkles in the décolleté area. Radiesse® is a regenerative biostimulator1 capable of regenerating multiple components of the skin tissue, resulting in healthier-looking skin,1,4,5 and is now approved for use in the décolleté area, adding to the product’s versatility.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, is proud to announce world-renowned actress, director and producer, Salma Hayek Pinault, as the first-ever global brand ambassador for Ultherapy PRIME.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the findings of its inaugural global study, Pillars of Confidence: Global Insights on Aesthetics and Self-Affirmation. The study explored the role confidence plays in daily life and overall well-being, as well as the connection between our internal selves and outward expression.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the launch of Ultherapy PRIME – a noninvasive, FDA-cleared medical aesthetics treatment that provides a truly personalized and long-lasting lift of the skin in one session with zero downtime.1

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the U.S. Food and Drug Administration (FDA) approved XEOMIN® (incobotulinumtoxinA) as the first and only neurotoxin for the simultaneous treatment of upper facial lines – forehead lines, frown lines and crow’s feet.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, announced today the launch of a new comprehensive educational ecosystem – MAX Merz Aesthetics Exchange. Rooted in trusted, science-based aesthetics expertise, the online platform offers an inclusive approach to professional development that transcends traditional boundaries, ensuring a transformative educational experience tailored to meet the evolving needs of health care professionals.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced the latest extension of their first-of-its kind, multi-year campaign, ‘Beauty on Your Terms’ with the addition of award-winning actor and musician Demi Lovato as the newest XEOMIN® (incobotulinumtoxinA) brand partner.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the U.S. Food and Drug Administration (FDA) approved Belotero Balance® (+) for volume augmentation for the improvement of the infraorbital hollow (IOH) in adults over the age of 21, further expanding the usage and capability of Belotero Balance® (+), and addressing consumer under-eye concerns.

Just in time for the brand’s 20th anniversary, NEOCUTIS, the science-based skincare line from Merz Aesthetics, is launching its new Neo Restore Post Treatment Nourishing Sheet Mask.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced another expansion to the ground-breaking ‘Beauty on Your Terms’ marketing campaign with Christina Aguilera as the latest Xeomin® (incobotulinumtoxinA) brand partner. Launched in August 2022, the campaign features multiple music icons in support of Xeomin® (pronounced phonetically: Zeo-min), an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the launch of the organization’s new corporate visual identity. The refreshed look underscores Merz Aesthetics’ commitment to putting the definition of beauty back into the hands of the individual through a vibrant and distinct color palette along with strong and joyful photography.

Merz Aesthetics®, the world’s largest dedicated medical aesthetics business, today announced Joe Jonas as the latest Xeomin® (incobotulinumtoxinA) brand partner. The U.S. partnership with Jonas kicks off a new, ground-breaking ‘Beauty on Your Terms’ campaign for Xeomin® and represents the first time the singer, songwriter and actor has partnered with an aesthetics brand. Xeomin® (pronounced phonetically: Zeo-min) is an FDA-approved double filtered anti-wrinkle injection to temporarily help improve the appearance of frown lines with only the ingredients that work and none that don’t.

Merz Aesthetics, the world's largest dedicated medical aesthetics business, is pleased to kick off a new partnership with the North Carolina Courage, reigning NWSL Challenge Cup Champions and two-time champions of the National Women's Soccer League (NWSL).

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today the commercial launch of Radiesse® (+) Lidocaine injectable implant for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to severe loss of jawline contour in adults over the age of 21. Radiesse Injectables represent the first and only calcium hydroxylapatite (CaHA) portfolio in the U.S., and Radiesse (+) is the first and only FDA-approved injectable treatment for jawline contour improvement. The U.S. Food and Drug Administration (FDA) approved the supplemental Premarket Approval Application (sPMA) in September 2021.

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, today announced the latest initiative focused on its Confidence to Be platform, a global effort to celebrate confidence and spark conversation around the unique things that make each person feel their best. Confidence is at the core of Merz Aesthetics’ purpose, with this initiative underscoring the commitment to inspire customers, patients and employees to connect through their own personal stories.